Visionary Education Technology (US:GV) Globenewswire·2026-03-05 14:30Core Insights - Visionary Holdings Inc. is focusing on expanding its presence in the global healthcare and medical aesthetics markets, particularly in North America and Europe, as part of its strategic growth priorities for 2026-2027 [1][2][4] Business Outlook - The period from 2026 to 2027 is expected to be crucial for the commercialization of the RAMU anti-aging product line, which is anticipated to drive significant revenue growth [4][9] - Management estimates that RAMU-related product sales could potentially reach approximately US$30 million annually, depending on market conditions and operational execution [5] Strategic Growth Priorities - The company plans to continue its expansion into international medical aesthetics markets through product commercialization, distribution partnerships, and healthcare service collaborations [7] - Visionary aims to accelerate the commercialization of its RAMU anti-aging product line, targeting premium applications in medical aesthetics and regenerative healthcare [7] - Development of integrated healthcare service platforms that combine medical aesthetics products, wellness services, and advanced biotechnology applications is also a priority [8] Management Commentary - The CEO of Visionary Holdings emphasized the importance of the upcoming period for the company's strategic transition towards healthcare services and medical aesthetics, highlighting the potential for meaningful growth opportunities [9][10]